Reuters - Japan’s Takeda Pharmaceutical and U.S. Amylin Pharmaceuticals said on Monday they will co-develop and commercialize drugs to treat obesity, including two Amylin drugs in mid-stage trials.
More: continued here
If you like this post, please buy me a beer for $3 8-)
Blogsphere: TechnoratiFeedsterBloglines
Bookmark: Del.icio.usSpurlFurlSimpyBlinkDigg
RSS feed for comments on this post | TrackBack URI for this post
Best Deal Ads :
Leave a Reply
Resources
Blog Categories
Monthly Archives
By Month
- April 2012 (20)
- March 2012 (56)
- February 2012 (35)
- January 2012 (36)
- December 2011 (44)
- November 2011 (39)
- October 2011 (28)
- September 2011 (28)
- August 2011 (35)
- July 2011 (29)
- June 2011 (39)
- May 2011 (28)
- April 2011 (36)
- March 2011 (39)
- February 2011 (40)
- January 2011 (28)
- December 2010 (39)
- November 2010 (27)
- October 2010 (34)
- September 2010 (53)
- August 2010 (38)
- July 2010 (42)
- June 2010 (31)
- May 2010 (27)
- April 2010 (36)
- March 2010 (46)
- February 2010 (44)
- January 2010 (35)
- December 2009 (10)
- November 2009 (21)
- October 2009 (24)
- September 2009 (27)
- August 2009 (9)
- July 2009 (32)
- June 2009 (88)
- May 2009 (79)
- April 2009 (90)
- March 2009 (76)
- February 2009 (79)
- January 2009 (68)
- December 2008 (88)
- November 2008 (70)
- October 2008 (88)
- September 2008 (86)
- August 2008 (79)
- July 2008 (94)
- June 2008 (66)
- May 2008 (58)
- April 2008 (77)
- March 2008 (81)
- February 2008 (76)
- January 2008 (94)
- December 2007 (36)
Recent Comments:
Recent Trackbacks:
